Around 15–20% of CRPC tumors eventually become independent of AR signaling, though detecting this shift in clinical practice remains difficult; one notable sign is the histologic progression from AR-positive adenocarcinoma to AR-negative, poorly differentiated small cell neuroendocrine carcinoma [187]. Here, AR is linked to adenocarcinoma.